Niese D - Search Results

1

Cold ischemia, histocompatibility, donor and recipient age: impact on early lymphocyte subsets and transplant outcome.

Jacobs U, Niese D, Klein B, Paar D, Miersch WD, Klehr HU. Jacobs U, et al. Among authors: niese d. Transplant Proc. 1996 Dec;28(6):3251-2. Transplant Proc. 1996. PMID: 8962260 No abstract available.

2

Clinical and immunologic characteristics of transplant recipients with recurrent acute rejection episodes.

Jacobs U, Niese D, Brensing KA, Klein B, Buszello H, Klehr HU. Jacobs U, et al. Among authors: niese d. Transplant Proc. 1996 Dec;28(6):3231-3. Transplant Proc. 1996. PMID: 8962250 No abstract available.

3

Immunologic disorders in posttransplant lymphoma: therapeutic implications.

Jacobs U, Niese D, Brensing KA, Eis-Hübinger A, Buszello H, Klehr HU. Jacobs U, et al. Among authors: niese d. Transplant Proc. 1996 Dec;28(6):3249-50. Transplant Proc. 1996. PMID: 8962259 No abstract available.

4

Acute rejection relapses posttransplant: definition of risk group and evaluation of potent therapeutic regimens.

Jacobs U, Niese D, Miersch WD, Klehr HU. Jacobs U, et al. Among authors: niese d. Transpl Int. 1996;9 Suppl 1:S34-7. doi: 10.1007/978-3-662-00818-8_10. Transpl Int. 1996. PMID: 8959786

5

Use of Sandimmun Neoral in renal transplant patients. International Sandimmun Neoral Study Group.

Frei U, Taesch S, Niese D. Frei U, et al. Among authors: niese d. Transplant Proc. 1994 Oct;26(5):2928-31. Transplant Proc. 1994. PMID: 7940925 Clinical Trial. No abstract available.

6

Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.

Frei UA, Neumayer HH, Buchholz B, Niese D, Mueller EA. Frei UA, et al. Among authors: niese d. Transplantation. 1998 Jun 15;65(11):1455-60. doi: 10.1097/00007890-199806150-00008. Transplantation. 1998. PMID: 9645802 Clinical Trial.

7

Sandimmun neoral, a new oral formulation of cyclosporin A with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients.

Taesch S, Niese D, Mueller EA. Taesch S, et al. Among authors: niese d. Transplant Proc. 1994 Dec;26(6):3147-9. Transplant Proc. 1994. PMID: 7998097 Clinical Trial. No abstract available.

8

Safety and tolerability of Neoral in transplant recipients.

Feutren G, Wong R, Jin J, Niese D, Mellein B. Feutren G, et al. Among authors: niese d. Transplant Proc. 1996 Aug;28(4):2177-82. Transplant Proc. 1996. PMID: 8769193 Clinical Trial. No abstract available.

9

A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.

Niese D. Niese D. Transplant Proc. 1995 Apr;27(2):1849-56. Transplant Proc. 1995. PMID: 7725531 Clinical Trial. No abstract available.

10

Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.

Kovarik JM, Mueller EA, Richard F, Niese D, Halloran PF, Jeffery J, Paul LC, Keown PA. Kovarik JM, et al. Among authors: niese d. Transplantation. 1996 Sep 27;62(6):759-63. doi: 10.1097/00007890-199609270-00010. Transplantation. 1996. PMID: 8824473 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters